Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 208,823 | reported | 06 May 2026 | tx 73+432,177−188,750 |
| Oruka Therapeutics, Inc. | 86,978 | reported | 21 May 2026 | tx 11+196,243−167,260 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 38,689 | 6.84 USD | 10b5-1 |
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 11,904 | 7.80 USD | 10b5-1 |
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 11,667 | 11.77 USD | 10b5-1 |
| 21 May 2026 | SALE | Oruka Therapeutics, Inc. | 38,318 | 58.43 USD | 10b5-1 |
| 21 May 2026 | SALE | Oruka Therapeutics, Inc. | 53,447 | 59.10 USD | 10b5-1 |
| 21 May 2026 | SALE | Oruka Therapeutics, Inc. | 13,235 | 59.97 USD | 10b5-1 |
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 38,689 | 0.00 USD | 10b5-1deriv |
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 11,904 | 0.00 USD | 10b5-1deriv |
| 21 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 11,667 | 0.00 USD | 10b5-1deriv |
| 06 May 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 22.86 USD | 10b5-1 |
| 06 May 2026 | SALE | Apogee Therapeutics, Inc. | 3,700 | 83.92 USD | 10b5-1 |
| 06 May 2026 | SALE | Apogee Therapeutics, Inc. | 1,800 | 84.60 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 0.00 USD | 10b5-1deriv |
| 04 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 2,075 | 71.98 USD | |
| 04 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 3,225 | 70.33 USD | |
| 04 Mar 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 22.86 USD | |
| 04 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 200 | 73.26 USD | |
| 04 Mar 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 0.00 USD | deriv |
| 04 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 100 | 67.88 USD | |
| 04 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 2,481 | 64.88 USD | |
| 04 Feb 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 22.86 USD | |
| 04 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 1,299 | 66.85 USD | |
| 04 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 1,420 | 65.83 USD | |
| 04 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 200 | 68.94 USD | |
| 04 Feb 2026 | EXERCISE | Apogee Therapeutics, Inc. | 4,125 | 0.00 USD | deriv |